100 on 100: Heart of Vermont Relay supporting The Boys & Girls Club of Vermont
The 100 on 100, Heart of Vermont Relay is an annual race through Vermont that supports The Boys & Girls Club of Vermont. As an affiliate of the Boys & Girls Clubs of America, the Boys & Girls Club of Vermont is one of 4,000 clubs nationally that has been dedicated to serving America’s youth for over 100 years. As participants of the 100 on 100 for the second consecutive year, Galen is excited to return to the event and act as part of the effort.
Today the Clubs in Vermont provide after school, evening, weekend and summer programming to over 2,300 youth, ages 5 – 19 each year. BGCA’s mission is to inspire and enable all youth, regardless of circumstances, to realize their full potential as productive, responsible and caring citizens. The Clubs provide a safe place to learn and grow ongoing relationships with caring, adult professionals, life-enhancing programs and character development experiences.
BGCA programs and services are designed to promote and enhance the development of boys and girls by instilling:
- A sense of competence – the feeling that there is something boys and girls can do well.
- A sense of usefulness – the opportunity to do something of value for other people.
- A sense of belonging – a setting where young people know they “fit” and are accepted.
- A sense of power and influence – a chance to be heard and to influence decisions.
Clubs exist in every corner of the country – in public housing, schools, homeless shelters, shopping malls, military bases and Native American lands, among others. For more information on the National movement visit www.bgca.org
Breast Cancer 3-Day
In October of 2008, Cynthia Gerson joined thousands of women and men to take part of the Breast Cancer 3-Day walk. With the help of Galen Healthcare Solutions and other generous contributors, Cyn was able to exceed her minimum required fundraising goal.
This 60-mile journey is held each year to celebrate survivors, honor lives lost, promote breast cancer research and help bring breast cancer care to those who so desperately need it. Eighty-five percent of net proceeds from this event benefits Susan G. Komen for the Cure to fund breast cancer research, education, screening and treatment programs. The remainder of the proceeds go to The National Philanthropic Trust Breast Cancer Fund, which provides ongoing support to breast cancer initiatives.
The 2008 Breast Cancer 3-Day Series, which took place in 14 cities nationwide, raised more than $110 million through donations, contributions and sponsorships.
To learn more about the Breast Cancer 3-Day, visit http://www.the3day.org
Rett Syndrome Research Trust
The goal of the Rett Syndrome Research Trust is to deliver clinical trials of a novel treatment strategy within five years.
The Rett Syndrome Research Trust is a newly formed 501(c)(3) nonprofit organization intensively focused on the development of treatments and cures for Rett Syndrome and related MECP2 disorders. The strength of the Trust is based on the guidance of founders and advisors who are largely responsible for the major advances in Rett research over the past decade.
In February of 2007, the journal Sciencepublished a paper by Adrian Bird, Ph.D., demonstrating the reversal of Rett Syndrome in mature mouse models with late stage disease. This remarkable and unexpected result has established a new paradigm for Rett Syndrome and other neuropsychiatric conditions, such as autism and schizophrenia.
The obvious and urgent question the Trust seeks to answer is whether symptoms can be reversed and normal function restored, in people suffering with Rett Syndrome and MECP2 spectrum disorders. To this end, the Trust has convened a series of international think tanks and developed a comprehensive, strategic portfolio of projects, including the first foray into drug discovery for Rett Syndrome. This plan was developed in concert with, and will be executed by, distinguished scientists who are thought-leaders in their fields.
In honor of Emma Foley, Galen became involved with the Rett Syndrome Research Trust in November of 2008 and encourages everyone to join the effort to help Rett Syndrome become the first reversible childhood neurological disorder. A private effort is essential if treatments and cures are to be developed in a time frame that the devastating nature of this disorder demands. Please visit http://www.rsrt.org/ for more information.